$0.71
▼ -1.5% Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
Daré Bioscience (DARE) Q2 2026 Earnings Call Transcript
Dare Bioscience Inc (DARE) (Q2 2026) Earnings Call Highlights: Commercial Launch Milestones and ...
Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall
Overview
52-week range
$0.69
$3.78
1% of range
Avg surprise (last 3)
+26.1%
Avg reaction (last 2)
+0.5%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.20 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-0.20 | $-0.33 | +39.4% | +60.0% | +0.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.28 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.45 | $-0.55 | +18.2% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.50 | $-0.63 | +20.6% | — | +0.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.55 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.52 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.81 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.09 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.22 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.09 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $187,546 | $152,455 | — | $2,262 | — | $25,427 | — | $41,691 |
| Cost of revenue | $319,889 | $242,325 | — | — | $0 | $0 | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-3M | — | $-4M | $-4M | $-5M | — | $-5M |
| Net income | $-3M | $-3M | — | $-4M | $-4M | $-4M | — | $-5M |
| EPS (diluted) | $-0.20 | $-0.21 | — | $-0.28 | $-0.45 | $-0.50 | — | $-0.55 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $19M | $25M | $23M | $5M | $10M | $16M | $11M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $17M | $22M | $27M | $25M | $7M | $12M | $18M | $15M |
| Total assets | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $23M | $27M | $30M | $28M | $26M | $28M | $28M | $20M |
| Total equity | $-560,100 | $734,451 | $3M | $3M | $-13M | $-10M | $-6M | $-1M |
Implied volatility — last 90 days
No IV snapshots yet for DARE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.